Management of urinary tract infections in children: antimicrobial sensitivity pattern, efficacy and pharmacoeconomics
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20192203Keywords:
Cost effective ratio, Fever, Urinary tract infectionAbstract
Background: Urinary tract infections are commonly seen in febrile children, high incidence of Vesico Ureteral Reflux (VUR) is frequently seen in paediatric patient which is of concern as it may lead to renal scarring. Despite presence of established clinical guidelines there is disparity amongst physician in the diagnosis and treatment of UTI, some physician prescribes taking into consideration the symptoms, some prescribe on the basis of smell and colour and some rely on urine culture and sensitivity report. There is dearth of studies in many tertiary health care centers regarding antimicrobial use. Authors conducted this study to evaluate antimicrobial sensitivity pattern, efficacy and cost effectiveness of antimicrobials used for UTI in children.
Methods: Patients of urinary tract infection <13 years of age were included in the study. Symptoms of patient i.e. pain in abdomen, haematuria, increased frequency of urination and degree of fever were recorded. Efficacy was measured through calculating degree of defervescence per hour. Cost effective model was prepared by calculating cost effective ratio i.e. dividing cost of antimicrobial required to bring down the fever and degree through which fever came down.
Results: E. coli was the most common pathogen isolated from urine positive culture (69.07%). Nitrofurantoin has shown highest sensitivity to all uropathogens (72.73%). Cotrimoxazole, ciprofloxacin and nitrofurantoin were found to be most cost effective.
Conclusions: In this current study authors found E coli is the most common uropathogen isolated. Ceftriaxone, cefixime, cotrimoxazole and amikacin were found to be most efficacious. Cotrimoxazole, ciprofloxacin and nitrofurantoin were found to be most cost effective.
Metrics
References
Urinary Tract Infection: Symptoms, Diagnosis, and Treatment. Healthline, 2015. Available at: https://www.healthline.com/health/urinary-tract-infection-adults. Accssed at 8 Sep 2018.
Rezaee MA, Abdinia B. Etiology and antimicrobial susceptibility pattern of pathogenic bacteria in children subjected to UTI. Medicine (Baltimore), 2015. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616821/. Accessed 7 Sep 2018.
Freedman AL. Urologic diseases in North America project: trends in resource utilization for urinary tract infections in children. J Urol. 2005;173(3):949-54.
Montini G, Tullus K, Hewitt I. Febrile urinary tract infections in children. N Engl J Med. 2011;365(3):239-50.
The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652790/. Accessed 31 Aug 2018.
Kaushik V, Chaudhary SR. Study for prevalence of urinary tract infection (UTI) in febrile children and to assess the validity of microscopic urine analysis in the diagnosis of UTI. Urin Tract Infect. 2017;4(4):4.
Yakubov R, Akker M, Machamad K, Hochberg A, Nadir E, Klein A. Antimicrobial resistance among uropathogens that cause childhood community-acquired urinary tract infections in Central Israel. Pediatr Infect Dis J. 2017;36(1):113-5.
Badhan R, Singh DV, Badhan LR, Kaur A. Evaluation of bacteriological profile and antibiotic sensitivity patterns in children with urinary tract infection: a prospective study from a tertiary care center. Ind J Urol. Available at: http://www.indianjurol.com/article.asp?issn=0970-1591;year=2016;volume=32;issue=1;spage=50;epage=56;aulast=Badhan. Accessed 31 Aug 2018.
Bader MS, Loeb M, Brooks AA. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2017;129(2):242-58.
Stein R, Dogan HS, Hoebeke P, Kočvara R, Nijman RJM, Radmayr C, et al. Urinary tract infections in children: EAU/ESPU guidelines. Eur Urol. 2015;67(3):546-58.
Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Available at: ://www.sciencedirect.com/shttpscience/article/pii/S0002934302010549. Accessed 31 Aug 2018.
Estill J, Salazar-Vizcaya L, Blaser N, Egger M, Keiser O. The cost-effectiveness of monitoring strategies for antiretroviral therapy of HIV infected patients in resource-limited settings: software tool. PloS One. 2015;10(3):e0119299.
Fenwick EAL, Briggs AH, Hawke CI. Management of urinary tract infection in general practice: a cost-effectiveness analysis. Br J Gen Pract. 2000;5.
Vallejo-Torres L, Pujol M, Shaw E, Wiegand I, Vigo JM, Stoddart M, et al. Cost of hospitalized patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the combacte-magnet, rescuing study. BMJ Open. 2018;8(4):e020251.
Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis. 2013;13:19.
Mashouf RY, Babalhavaeji H, Yousef J. Urinary tract infections: bacteriology and antibiotic resistance patterns. Ind Pediatr. 2009;46(7):617-20.
Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob. 2007;6:4.
Kumurya A, Yashua AH, Uba A. Organisms causing urinary tract infection in pediatric patients at Murtala Mohammed Specialist Hospital, Kano, Nigeria. Int J Biomed Health Sci. 2008;4:165-7.
Brkic S, Mustafic S, Nuhbegovic S, Ljuca F, Gavran L. Clinical and epidemiology characteristics of urinary tract infections in childhood. Med Arh. 2010;64(3):135-8.
Kalantar E, Motlagh M esmaeel, Lornejad H, Reshadmanesh N. Prevalence of urinary tract pathogens and antimicrobial susceptibility patterns in children at hospitals in Iran. Arch Clin Infect Dis. 2008;3(3). Accessed 5 September 2018. Available at: http://journals.sbmu.ac.ir/infectiousinvisible/article/view/209.
Taneja N, Chatterjee SS, Singh M, Singh S, Sharma M. Pediatric urinary tract infections in a tertiary care center from north India. Indian J Med Res. 2010;5.
Sharma A, Shrestha S, Upadhyay S, Rijal P. Clinical and bacteriological profile of urinary tract infection in children at Nepal Medical College Teaching Hospital. Nepal Med Coll J NMCJ. 2011;13(1):24-6.
Shaw KN, Gorelick M, McGowan KL, Yakscoe NM, Schwartz JS. Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics. 1998;102(2):e16-e16.
Christopher A, Mshana SE, Kidenya BR, Hokororo A, Morona D. Bacteremia and resistant gram-negative pathogens among under-fives in Tanzania. Ital J Pediatr. 2013;39:27.
VG. Antibiotic resistance pattern in uropathogens. Ind J Med Microbiol. 2002;20(2):96.
Habte TM, Dube S, Ismail N, Hoosen AA. Hospital and community isolates of uropathogens at a tertiary hospital in South Africa. South Afr Med J Suid-Afr. 2009;99(8):584-7.
Biswas D, Gupta P, Prasad R, Singh V, Arya M, Kumar A. Choice of antibiotic for empirical therapy of acute cystitis in a setting of high antimicrobial resistance. Ind J Med Sci. 2006;60(2):53-8.
Sharmin S, Alamgir F, Fahmida M, Saleh AA. Antimicrobial sensitivity pattern of uropathogens in children. Bangladesh J Med Microbiol. 2010;3(2):18.
Prais D, Straussberg R, Avitzur Y, Nussinovitch M, Harel L, Amir J. Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection. Arch Dis Child. 2003;88(3):215-8.
Chang U-I, Kim HW, Wie S-H. Comparison of second- and third-generation cephalosporin as initial therapy for women with community-onset uncomplicated acute pyelonephritis. Yonsei Med J. 2015;56(5):1266-73.
Montini G, Toffolo A, Zucchetta P, Dall’Amico R, Gobber D, Calderan A, et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. BMJ. 2007;335(7616):386.
Bosmans JE, Beerepoot MAJ, Prins JM, Riet G, Geerlings SE. Cost-Effectiveness of cranberries vs antibiotics to prevent urinary tract infections in premenopausal women: a randomized clinical trial. PLoS One. 2014;9(4).